Hypertension is a major cause of premature death worldwide. Hypertension not only causes coronary heart disease, myocardial infarction, heart failure, cerebral infarction and cerebral hemorrhage, but also leads to renal damage and even renal failure. The mechanism of kidney damage has two aspects: Blood vessel constriction leading to high blood pressure, eventually leading up to permanent ischemic kidney damage.
Therefore, it’s important to treat high blood pressure early to prevent prolonged kidney damage. While controlling blood pressure, it is necessary to reduce the burden on the kidneys to avoid the adverse effects of excessive blood pressure on the kidneys and promote long-term kidney health.
With the ideal of developing healthy solutions from marine sources, Chenland has been focusing on marine environmental biological research to explore the medicinal value of natural marine ingredients. During our latest studies, we have found that natural clams can provide considerable health benefits. In this way, a new mystery from the deep ocean was uncovered.
ClamBP™ is a new generation of all-natural marine based dietary supplement that can effectively help improve blood pressure and help nourish kidney health at the same time. As the first antihypertensive peptide product developed using patented enzymatic hydrolysis technology (EnzyTide™), ClamBP™ has innovative features such as high product yield, mild and easy-to-control production conditions, high safety, and many more product advantages. As the world’s first company to successfully develop a nutritionally beneficial functional peptides of clams, we believe that ClamBP™ will be a key ingredient-grade product to pave the pathway to blood pressure and kidney health.
The results of an 8-week open-label clinical study show that ClamBP™ is safe and effective in reducing high blood pressure. The results showed that systolic blood pressure (SBP) dropped from grade I hypertension to high normal blood pressure, and diastolic blood pressure (DBP) returned to normal.
BUN (Blood urea nitrogen) testing can provide a basis for the assessment of kidney damage. Compared with placebo, ClamBP™ can effectively reduce the concentration of BUN.
At the same time, ClamBP™ can reduce the concentration of ACE in the kidney of SHRs and increase the concentration of ACE2, which shows that ClamBP™ can effectively boost and protect kidney health.
ClamBP™ is extracted from natural clams, therefore, this nutrient does not have any toxic side effects. These are advantages that general antihypertensive drugs cannot compare. This latest research discovery will further develop a broader application scenario for dietary supplement and health, bring good news to people suffering from high blood pressure, and provide safer and more effective options for helping stabilize normal blood pressure and nourishing long-term kidney health.